Skip to main navigation Skip to search Skip to main content

Data from Johns Hopkins University School of Medicine Advance Knowledge in Liver Cancer (Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors)

Press/Media

Period24 Nov 2022

Media coverage

1

Media coverage